Examining the Usage, User Experience, and Perceived Impact of an Internet-Based Cognitive Behavioral Therapy Program for Adolescents With Anxiety: Randomized Controlled Trial.

adolescents anxiety clinical effectiveness cognitive behavioral therapy computer-assisted therapy internet minimal clinically important difference satisfaction treatment adherence

Journal

JMIR mental health
ISSN: 2368-7959
Titre abrégé: JMIR Ment Health
Pays: Canada
ID NLM: 101658926

Informations de publication

Date de publication:
07 Feb 2020
Historique:
received: 07 08 2019
accepted: 16 12 2019
revised: 02 12 2019
entrez: 6 2 2020
pubmed: 6 2 2020
medline: 6 2 2020
Statut: epublish

Résumé

Internet-based cognitive behavioral therapy (iCBT) increases treatment access for adolescents with anxiety; however, completion rates of iCBT programs are typically low. Understanding adolescents' experiences with iCBT, what program features and changes in anxiety (minimal clinically important difference [MCID]) are important to them, may help explain and improve iCBT program use and impact. Within a randomized controlled trial comparing a six-session iCBT program for adolescent anxiety, Being Real, Easing Anxiety: Tools Helping Electronically (Breathe), with anxiety-based resource webpages, we aimed to (1) describe intervention use among adolescents allocated to Breathe or webpages and those who completed postintervention assessments (Breathe or webpage respondents); (2) describe and compare user experiences between groups; and (3) calculate an MCID for anxiety and explore relationships between iCBT use, experiences, and treatment response among Breathe respondents. Enrolled adolescents with self-reported anxiety, aged 13 to 19 years, were randomly allocated to Breathe or webpages. Self-reported demographics and anxiety symptoms (Multidimensional Anxiety Scale for Children-2nd edition [MASC-2]) were collected preintervention. Automatically-captured Breathe or webpage use and self-reported symptoms and experiences (User Experience Questionnaire for Internet-based Interventions) were collected postintervention. Breathe respondents also reported their perceived change in anxiety (Global Rating of Change Scale [GRCS]) following program use. Descriptive statistics summarized usage and experience outcomes, and independent samples t tests and correlations examined relationships between them. The MCID was calculated using the mean MASC-2 change score among Breathe respondents reporting somewhat better anxiety on the GRCS. Adolescents were mostly female (382/536, 71.3%), aged 16.6 years (SD 1.7), with very elevated anxiety (mean 92.2, SD 18.1). Intervention use was low for adolescents allocated to Breathe (mean 2.2 sessions, SD 2.3; n=258) or webpages (mean 2.1 visits, SD 2.7; n=278), but was higher for Breathe (median 6.0, range 1-6; 81/258) and webpage respondents (median 2.0, range 1-9; 148/278). Total user experience was significantly more positive for Breathe than webpage respondents (P<.001). Breathe respondents reported program design and delivery factors that may have challenged (eg, time constraints and program support) or facilitated (eg, demonstration videos, self-management activities) program use. The MCID was a mean MASC-2 change score of 13.8 (SD 18.1). Using the MCID, a positive treatment response was generated for 43% (35/81) of Breathe respondents. Treatment response was not correlated with respondents' experiences or use of Breathe (P=.32 to P=.88). Respondents reported positive experiences and changes in their anxiety with Breathe; however, their reports were not correlated with program use. Breathe respondents identified program design and delivery factors that help explain their experiences and use of iCBT and inform program improvements. Future studies can apply our measures to compare user experiences between internet-based interventions, interpret treatment outcomes and improve treatment decision making for adolescents with anxiety. ClinicalTrials.gov Identifier: NCT02970734 https://clinicaltrials.gov/ct2/show/NCT02970734.

Sections du résumé

BACKGROUND BACKGROUND
Internet-based cognitive behavioral therapy (iCBT) increases treatment access for adolescents with anxiety; however, completion rates of iCBT programs are typically low. Understanding adolescents' experiences with iCBT, what program features and changes in anxiety (minimal clinically important difference [MCID]) are important to them, may help explain and improve iCBT program use and impact.
OBJECTIVE OBJECTIVE
Within a randomized controlled trial comparing a six-session iCBT program for adolescent anxiety, Being Real, Easing Anxiety: Tools Helping Electronically (Breathe), with anxiety-based resource webpages, we aimed to (1) describe intervention use among adolescents allocated to Breathe or webpages and those who completed postintervention assessments (Breathe or webpage respondents); (2) describe and compare user experiences between groups; and (3) calculate an MCID for anxiety and explore relationships between iCBT use, experiences, and treatment response among Breathe respondents.
METHODS METHODS
Enrolled adolescents with self-reported anxiety, aged 13 to 19 years, were randomly allocated to Breathe or webpages. Self-reported demographics and anxiety symptoms (Multidimensional Anxiety Scale for Children-2nd edition [MASC-2]) were collected preintervention. Automatically-captured Breathe or webpage use and self-reported symptoms and experiences (User Experience Questionnaire for Internet-based Interventions) were collected postintervention. Breathe respondents also reported their perceived change in anxiety (Global Rating of Change Scale [GRCS]) following program use. Descriptive statistics summarized usage and experience outcomes, and independent samples t tests and correlations examined relationships between them. The MCID was calculated using the mean MASC-2 change score among Breathe respondents reporting somewhat better anxiety on the GRCS.
RESULTS RESULTS
Adolescents were mostly female (382/536, 71.3%), aged 16.6 years (SD 1.7), with very elevated anxiety (mean 92.2, SD 18.1). Intervention use was low for adolescents allocated to Breathe (mean 2.2 sessions, SD 2.3; n=258) or webpages (mean 2.1 visits, SD 2.7; n=278), but was higher for Breathe (median 6.0, range 1-6; 81/258) and webpage respondents (median 2.0, range 1-9; 148/278). Total user experience was significantly more positive for Breathe than webpage respondents (P<.001). Breathe respondents reported program design and delivery factors that may have challenged (eg, time constraints and program support) or facilitated (eg, demonstration videos, self-management activities) program use. The MCID was a mean MASC-2 change score of 13.8 (SD 18.1). Using the MCID, a positive treatment response was generated for 43% (35/81) of Breathe respondents. Treatment response was not correlated with respondents' experiences or use of Breathe (P=.32 to P=.88).
CONCLUSIONS CONCLUSIONS
Respondents reported positive experiences and changes in their anxiety with Breathe; however, their reports were not correlated with program use. Breathe respondents identified program design and delivery factors that help explain their experiences and use of iCBT and inform program improvements. Future studies can apply our measures to compare user experiences between internet-based interventions, interpret treatment outcomes and improve treatment decision making for adolescents with anxiety.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov Identifier: NCT02970734 https://clinicaltrials.gov/ct2/show/NCT02970734.

Identifiants

pubmed: 32022692
pii: v7i2e15795
doi: 10.2196/15795
pmc: PMC7055748
doi:

Banques de données

ClinicalTrials.gov
['NCT02970734']

Types de publication

Journal Article

Langues

eng

Pagination

e15795

Informations de copyright

©Ashley D Radomski, Alexa Bagnell, Sarah Curtis, Lisa Hartling, Amanda S Newton. Originally published in JMIR Mental Health (http://mental.jmir.org), 07.02.2020.

Références

Adm Policy Ment Health. 2014 Jul;41(4):434-46
pubmed: 22829193
Arch Pediatr Adolesc Med. 2012 Dec;166(12):1170-6
pubmed: 23027429
J Med Internet Res. 2011 Apr 14;13(2):e32
pubmed: 21493191
PLoS One. 2015 Mar 18;10(3):e0119895
pubmed: 25786025
J Anxiety Disord. 2015 Jan;29:83-92
pubmed: 25527900
BMC Health Serv Res. 2016 Oct 10;16(1):562
pubmed: 27724951
Addict Behav. 2013 Mar;38(3):1747-56
pubmed: 23254225
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
J Med Internet Res. 2002 Jan-Mar;4(1):e3
pubmed: 11956035
Behav Ther. 2010 Jun;41(2):172-86
pubmed: 20412883
Curr Opin Rheumatol. 2002 Mar;14(2):109-14
pubmed: 11845014
BMJ. 1998 Feb 28;316(7132):690-3
pubmed: 9522799
Ann Behav Med. 2009 Aug;38(1):4-17
pubmed: 19787305
J Med Internet Res. 2016 Jun 30;18(6):e181
pubmed: 27363519
J Youth Adolesc. 2015 Jan;44(1):90-113
pubmed: 25115460
Psychol Med. 2008 Nov;38(11):1521-30
pubmed: 18205964
Health Promot Int. 2009 Sep;24(3):277-84
pubmed: 19515716
J Child Psychol Psychiatry. 2017 Apr;58(4):474-503
pubmed: 27943285
Behav Res Ther. 2017 Mar;90:67-75
pubmed: 28012300
J Med Internet Res. 2009 Apr 24;11(2):e13
pubmed: 19403466
Behav Res Ther. 2016 Jan;76:47-56
pubmed: 26649465
J Pediatr Psychol. 2009 Jun;34(5):474-87
pubmed: 18794187
Clin Child Fam Psychol Rev. 2019 Jun;22(2):147-171
pubmed: 30229343
J Man Manip Ther. 2009;17(3):163-70
pubmed: 20046623
Gen Hosp Psychiatry. 2011 Nov-Dec;33(6):543-55
pubmed: 21958447
Cogn Behav Pract. 2017 Nov;24(4):393-404
pubmed: 29056845
Lancet Child Adolesc Health. 2018 Nov;2(11):792-801
pubmed: 30241993
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
JMIR Mhealth Uhealth. 2016 Jul 28;4(3):e90
pubmed: 27468653
JMIR Ment Health. 2019 Apr 17;6(4):e12169
pubmed: 30994470
Med Care. 2000 Sep;38(9 Suppl):II175-9
pubmed: 10982104
Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004690
pubmed: 16235374
J Rheumatol. 2001 Feb;28(2):406-12
pubmed: 11246688
Int J Eat Disord. 2001 Sep;30(2):129-37
pubmed: 11449446
Behav Res Ther. 2017 Mar;90:41-57
pubmed: 27988427
J Med Internet Res. 2018 Jan 22;20(1):e12
pubmed: 29358158
BMJ Open. 2017 Dec 14;7(12):e018345
pubmed: 29247101
Control Clin Trials. 1989 Dec;10(4):407-15
pubmed: 2691207
E J Appl Psychol. 2008;4(2):32-42
pubmed: 20953264
Cogn Behav Ther. 2009;38 Suppl 1:55-60
pubmed: 19675956
Telemed J E Health. 2014 May;20(5):419-27
pubmed: 24579913
J Med Internet Res. 2017 Jan 09;19(1):e6
pubmed: 28069560
World Psychiatry. 2014 Feb;13(1):4-11
pubmed: 24497236
Transl Behav Med. 2017 Jun;7(2):254-267
pubmed: 27966189
Nurs Res. 2013 Jan-Feb;62(1):45-9
pubmed: 23114795
Cochrane Database Syst Rev. 2015 Mar 05;(3):CD011565
pubmed: 25742186
J Med Internet Res. 2012 Jun 28;14(3):e88
pubmed: 22789657
Spine J. 2007 Sep-Oct;7(5):541-6
pubmed: 17448732
J Med Internet Res. 2018 Jul 04;20(7):e234
pubmed: 29973338
J Med Internet Res. 2017 Aug 09;19(8):e266
pubmed: 28793983
J Med Internet Res. 2011 Aug 05;13(3):e52
pubmed: 21821503
Otolaryngol Head Neck Surg. 2007 Jan;136(1):14-8
pubmed: 17210326
J Am Acad Child Adolesc Psychiatry. 1997 Apr;36(4):545-53
pubmed: 9100430
Behav Res Ther. 2015 Apr;67:1-18
pubmed: 25727678
Internet Interv. 2018 Jan 06;11:30-40
pubmed: 30135757
J Med Internet Res. 2005 Mar 31;7(1):e11
pubmed: 15829473
Clin Psychol Rev. 2013 Jul;33(5):698-711
pubmed: 23742782
BMC Pediatr. 2015 Dec 16;15:213
pubmed: 26675420
Depress Anxiety. 2003;18(1):1-6
pubmed: 12900947
BMC Psychiatry. 2010 Dec 30;10:113
pubmed: 21192795
Pediatrics. 2017 Mar;139(3):
pubmed: 28196931
Pediatrics. 2005 Nov;116(5):e643-7
pubmed: 16263978
Expert Rev Pharmacoecon Outcomes Res. 2011 Apr;11(2):171-84
pubmed: 21476819
J Med Internet Res. 2018 Nov 16;20(11):e292
pubmed: 30446482
J Affect Disord. 2016 May 15;196:210-7
pubmed: 26926660
J Med Internet Res. 2019 Feb 05;21(2):e11128
pubmed: 30720436
Cogn Behav Ther. 2013;42(4):303-14
pubmed: 24245708
J Med Internet Res. 2009 Feb 23;11(1):e6
pubmed: 19275982
Am J Prev Med. 2016 Nov;51(5):833-842
pubmed: 27745683
Mayo Clin Proc. 2002 Apr;77(4):371-83
pubmed: 11936935
Psychiatr Serv. 2014 Jan 1;65(1):24-32
pubmed: 24081188
J Med Internet Res. 2017 Aug 01;19(8):e277
pubmed: 28765103
Can J Psychiatry. 2019 Apr;64(4):246-255
pubmed: 30978138
Arch Gen Psychiatry. 2003 Jul;60(7):709-17
pubmed: 12860775
J Clin Epidemiol. 1994 Jan;47(1):81-7
pubmed: 8283197
BMC Health Serv Res. 2014 Jul 18;14:313
pubmed: 25037951
J Consult Clin Psychol. 2006 Jun;74(3):614-21
pubmed: 16822117
J Med Internet Res. 2008 Jun 30;10(2):e16
pubmed: 18653440
Clin Psychol Rev. 2016 Dec;50:1-10
pubmed: 27668988
J Affect Disord. 2013 May;147(1-3):338-44
pubmed: 23245469
Int J Ment Health Syst. 2019 Jan 31;13:6
pubmed: 30733825
Can J Psychiatry. 2002 Nov;47(9):825-32
pubmed: 12500752
Ann Behav Med. 2009 Aug;38(1):18-27
pubmed: 19802647
Telemed J E Health. 2012 Mar;18(2):137-44
pubmed: 22381060
JMIR Res Protoc. 2016 Jan 29;5(1):e18
pubmed: 26825111
Med Care. 2003 May;41(5):582-92
pubmed: 12719681
Health Psychol. 2009 Nov;28(6):690-701
pubmed: 19916637
Clin Child Fam Psychol Rev. 2010 Sep;13(3):275-90
pubmed: 20532980
Arch Gen Psychiatry. 2003 Aug;60(8):837-44
pubmed: 12912767
Transl Behav Med. 2020 Feb 3;10(1):267-277
pubmed: 30927357
Internet Interv. 2017 Nov 09;12:121-129
pubmed: 30135776
Internet Interv. 2016 Aug 17;6:1-5
pubmed: 30135808
J Man Manip Ther. 2012 Aug;20(3):160-6
pubmed: 23904756
Internet Interv. 2018 Jun 01;16:86-97
pubmed: 30775268
J Consult Clin Psychol. 2011 Oct;79(5):629-42
pubmed: 21744945
Br J Clin Psychol. 2010 Nov;49(Pt 4):455-71
pubmed: 19799804
Cochrane Database Syst Rev. 2013 Jun 03;(6):CD004690
pubmed: 23733328

Auteurs

Ashley D Radomski (AD)

Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.

Alexa Bagnell (A)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Department of Psychiatry, Izaak Walton Killam Health Centre, Halifax, NS, Canada.

Sarah Curtis (S)

Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.

Lisa Hartling (L)

Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.

Amanda S Newton (AS)

Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.

Classifications MeSH